India Must Focus On Biopharmaceuticals To Feed The Growth Engine: Kiran Mazumdar Shaw

In an exclusive conversation with BW Healthcare World, Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Biocon Biologics delineates on how Indian pharma can move up the value chain, while also speaking on Biocon's R&D investments and future plans

What's Ahead In Pharma

India, known as the pharmacy of the world, is the 3rd biggest producer of medicines by volume and 14th by value. With a fleet of 3,000 domestic drug companies and 10,500 manufacturing units, the country enjoys a crucial place in the global pharmaceutical sector

India's Gland Pharma Jumps 23% In Market Debut

Pharma stocks are on a tear this year, with the Nifty Pharma Index up nearly 44%, far outpacing the 5% rise in the benchmark NSE Nifty 50 index.

Credit Metrics Of Leading Pharma Companies To Remain Stable: ICRA

The domestic pharmaceutical industry is highly dependent on imports with more than 60 per cent of its active pharmaceutical ingredients (API) requirement being imported.

Indian Pharma 'Sunrise' Segment, Year 2020 Prognosis Positive For Healthcare Sector

As for the healthcare sector, Apollo Hospitals Group MD Suneeta Reddy said, 'The prognosis is positive.'

US based NSF International Adds Pharma Biotech Services To India Office

India is one of the world's largest producers of generic pharmaceuticals and it is important for NSF International to be here

'Indian Pharma Sector Growth Likely To Come Down To Single Digit'

In ICRA’s view, continued regulatory interventions in domestic market will put some pressure in near term though long term growth prospects remain healthy given increasing penetration, accessibility and continued new launches by players.

Dr Reddy's Founder Anji Reddy Passes Away

Drugs Pricing: Relief For Cipla Till Aug 27